Aptose Biosciences (APTO) Short Interest Ratio & Short Volume $0.16 -0.03 (-14.68%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aptose Biosciences Short Interest DataAptose Biosciences (APTO) has a short interest of 993,200 shares, representing 1.76% of the float (the number of shares available for trading by the public). This marks a -24.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 16.94 million shares to cover all short positions.Current Short Interest993,200 sharesPrevious Short Interest1,310,000 sharesChange Vs. Previous Month-24.18%Dollar Volume Sold Short$174,803.20Short Interest Ratio0.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares64,300,000 sharesFloat Size56,470,000 sharesShort Percent of Float1.76%Today's Trading Volume8,860,452 sharesAverage Trading Volume16,936,996 sharesToday's Volume Vs. Average52% Short Selling Aptose Biosciences? Sign up to receive the latest short interest report for Aptose Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPTO Short Interest Over TimeAPTO Days to Cover Over TimeAPTO Percentage of Float Shorted Over Time Aptose Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025993,200 shares $174,803.20 -24.2%1.8%0.2 $0.18 1/15/20251,310,000 shares $269,991.00 -37.3%2.3%0.2 $0.21 12/31/20242,090,000 shares $470,877.00 +1,012.9%3.7%0.3 $0.23 12/15/2024187,800 shares $36,245.40 +84.5%0.3%0 $0.19 11/30/2024101,800 shares $18,324.00 -15.7%0.2%0.2 $0.18 11/15/2024120,700 shares $44,049.34 -2.0%0.8%0.2 $0.36 10/31/2024123,200 shares $46,902.24 -36.1%0.8%0.2 $0.38 10/15/2024192,700 shares $71,106.30 -6.4%1.3%0.4 $0.37 9/30/2024205,900 shares $84,604.31 -74.9%1.4%0.4 $0.41 9/15/2024818,700 shares $305,948.19 +520.2%5.5%1.5 $0.37 Get the Latest News and Ratings for APTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024132,000 shares $53,592.00 +167.2%0.9%0.3 $0.41 8/15/202449,400 shares $23,870.08 -45.8%0.3%0.6 $0.48 7/31/202491,200 shares $52,713.60 +12.9%0.6%1.2 $0.58 7/15/202480,800 shares $56,802.40 -13.1%0.5%1.2 $0.70 6/30/202493,000 shares $70,587.00 -17.6%0.6%1.6 $0.76 6/15/2024112,800 shares $100,392.00 +46.5%0.8%1.6 $0.89 5/31/202477,000 shares $75,075.00 +13.1%0.5%1.2 $0.98 5/15/202468,100 shares $82,401.00 -18.4%0.7%1 $1.21 4/30/202483,500 shares $100,200.00 +52.1%0.9%1.1 $1.20 4/15/202454,900 shares $71,370.00 -35.9%0.6%0.6 $1.30 3/31/202485,600 shares $142,096.00 +70.5%0.9%0.9 $1.66 3/15/202450,200 shares $76,304.00 -28.7%0.5%0.5 $1.52 2/29/202470,400 shares $126,720.00 -22.3%0.8%0.8 $1.80 2/15/202490,600 shares $183,265.68 -53.0%1.0%1 $2.02 1/31/2024192,600 shares $385,200.00 +31.9%6.2%2.5 $2.00 1/15/2024146,000 shares $332,880.00 +66.5%4.0%2.6 $2.28 12/31/202387,700 shares $222,758.00 +32.3%2.4%1.6 $2.54 12/15/202366,300 shares $157,131.00 +193.4%1.8%1.3 $2.37 11/30/202322,600 shares $54,918.00 -25.9%0.7%0.5 $2.43 11/15/202330,500 shares $82,655.00 -27.2%1.0%0.8 $2.71 10/31/202341,900 shares $116,901.00 +37.8%1.7%1 $2.79 10/15/202330,400 shares $65,056.00 -24.4%1.2%0.7 $2.14 9/30/202340,200 shares $112,560.00 +37.7%1.8%1 $2.80 9/15/202329,200 shares $96,068.00 -22.8%1.3%0.7 $3.29 8/31/202337,800 shares $153,090.00 -7.1%1.8%0.8 $4.05 8/15/202340,700 shares $199,430.00 -12.9%1.3%0.9 $4.90 7/31/202346,700 shares $144,770.00 -28.4%2.2%1.1 $3.10 7/15/202365,200 shares $288,836.00 -18.2%3.1%1.8 $4.43 6/30/202379,700 shares $369,808.00 -3.4%1.4%2.5 $4.64 6/15/202382,500 shares $485,925.00 +167.0%1.4%2.9 $5.89Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 5/31/202330,900 shares $190,035.00 -88.3%N/A1.6 $6.15 5/15/2023264,100 shares $124,655.20 +44.6%0.3%1.5 $0.47 4/30/2023182,700 shares $88,189.29 +11.3%0.2%1.1 $0.48 4/15/2023164,100 shares $84,027.41 -37.4%0.2%0.9 $0.51 3/31/2023262,200 shares $167,808.00 +53.3%0.3%1.4 $0.64 3/15/2023171,000 shares $99,180.00 -3.0%0.2%0.8 $0.58 2/28/2023176,200 shares $102,548.40 +0.7%0.2%0.6 $0.58 2/15/2023175,000 shares $119,000.00 -13.9%0.2%0.6 $0.68 1/31/2023203,300 shares $152,475.00 -74.0%0.2%0.7 $0.75 1/15/2023782,400 shares $547,680.00 -19.6%0.9%1.8 $0.70 12/30/2022973,500 shares $564,630.00 -3.6%N/A2.3 $0.58 12/15/20221,010,000 shares $591,153.00 +29.1%N/A2.5 $0.59 11/30/2022782,300 shares $520,229.50 +13.0%N/A2.2 $0.67 11/15/2022692,100 shares $472,289.04 +163.7%N/A1.9 $0.68 10/31/2022262,500 shares $120,881.25 -4.0%N/A0.7 $0.46 10/15/2022273,300 shares $155,808.33 +14.6%N/A1.3 $0.57 9/30/2022238,400 shares $141,848.00 -2.9%N/A1.3 $0.60 9/15/2022245,600 shares $170,937.60 +18.7%N/A1.3 $0.70 8/31/2022206,900 shares $161,795.80 -15.9%N/A1 $0.78 8/15/2022245,900 shares $213,933.00 -16.7%N/A1.1 $0.87 7/31/2022295,100 shares $218,993.71 +10.5%N/A1.1 $0.74 7/15/2022267,100 shares $223,055.21 +4.8%N/A0.9 $0.84 6/30/2022255,000 shares $189,235.50 -38.2%N/A0.7 $0.74 6/15/2022412,300 shares $349,671.63 -16.3%N/A1 $0.85 5/31/2022492,500 shares $497,425.00 +0.4%0.6%1.2 $1.01 5/15/2022490,800 shares $510,432.00 +5.0%0.6%1.2 $1.04 4/30/2022467,500 shares $556,325.00 +5.9%0.6%1.1 $1.19 4/15/2022441,500 shares $551,875.00 +3.8%0.5%1.1 $1.25 3/31/2022425,400 shares $578,544.00 -4.8%0.5%1 $1.36 3/15/2022446,600 shares $473,396.00 -21.7%0.6%0.9 $1.06 2/28/2022570,400 shares $684,480.00 +2.8%0.7%0.6 $1.20 2/15/2022554,900 shares $682,527.00 -5.7%0.7%0.6 $1.23 1/31/2022588,200 shares $764,660.00 -3.8%0.7%0.5 $1.30 1/15/2022611,700 shares $819,678.00 -4.2%0.8%0.5 $1.34 12/31/2021638,400 shares $861,840.00 -11.7%0.8%0.5 $1.35 12/15/2021722,700 shares $860,013.00 -2.9%0.9%0.6 $1.19 11/30/2021744,300 shares $1.64 million -16.3%0.9%0.9 $2.20 11/15/2021889,100 shares $2.29 million -5.2%1.1%1 $2.58 10/29/2021937,600 shares $1.92 million +2.4%1.2%1 $2.05 10/15/2021916,100 shares $2.11 million +16.6%1.2%1 $2.30 9/30/2021785,600 shares $1.71 million -16.7%1.0%0.8 $2.18 9/15/2021942,600 shares $2.55 million -7.6%1.2%0.9 $2.71 8/31/20211,020,000 shares $3.05 million -12.8%1.3%0.7 $2.99 8/13/20211,170,000 shares $3.08 million -7.9%1.5%0.9 $2.63 7/30/20211,270,000 shares $3.42 million -24.4%1.7%1 $2.69 7/15/20211,680,000 shares $4.80 million -42.3%2.0%1.4 $2.86 6/30/20212,910,000 shares $9.66 million -4.0%3.5%2.4 $3.32 6/15/20213,030,000 shares $10.61 million -1.3%3.7%0.7 $3.50 5/28/20213,070,000 shares $16.27 million -1.3%3.7%0.8 $5.30 5/14/20213,110,000 shares $14.37 million -7.4%3.8%0.8 $4.62Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 4/30/20213,360,000 shares $18.92 million -8.9%4.1%0.8 $5.63 4/15/20213,690,000 shares $19.22 million -23.1%4.5%0.9 $5.21 3/31/20214,800,000 shares $29.86 million +98.4%5.9%1.1 $6.22 3/15/20212,420,000 shares $9.56 million +8.0%3.0%0.6 $3.95 2/26/20212,240,000 shares $8.92 million +1.8%2.7%1.5 $3.98 2/12/20212,200,000 shares $10.23 million -26.7%2.7%1.5 $4.65 1/29/20213,000,000 shares $12.75 million -11.8%3.6%1.9 $4.25 1/15/20213,400,000 shares $14.93 million -24.8%4.0%2.1 $4.39 12/31/20204,520,000 shares $19.26 million -3.8%5.4%2.8 $4.26 12/15/20204,700,000 shares $18.99 million +49.2%5.6%3.1 $4.04 11/30/20203,150,000 shares $19.78 million +38.2%3.8%2.3 $6.28 11/15/20202,280,000 shares $12.22 million +7.6%2.7%2.3 $5.36 10/30/20202,120,000 shares $9.75 million +12.8%2.6%2.5 $4.60 10/15/20201,880,000 shares $11.05 million -25.7%2.3%2.1 $5.88 9/30/20202,530,000 shares $15.18 million +5.0%3.1%2.6 $6.00 9/15/20202,410,000 shares $14.24 million +24.9%2.9%2.5 $5.91 8/31/20201,930,000 shares $10.81 million -5.9%2.3%2 $5.60 8/14/20202,050,000 shares $10.50 million -5.5%2.5%2.5 $5.12 7/31/20202,170,000 shares $10.98 million +22.6%2.7%2.5 $5.06 7/15/20201,770,000 shares $10.05 million +9.9%2.2%2 $5.68 6/30/20201,610,000 shares $10.16 million -13.4%2.3%2.1 $6.31 6/15/20201,860,000 shares $12.74 million +2.2%2.6%2.4 $6.85 5/29/20201,820,000 shares $13.43 million -8.1%2.6%2.1 $7.38 5/15/20201,980,000 shares $15.58 million +99.7%2.8%2.1 $7.87 4/30/2020991,600 shares $6.85 million +59.6%1.4%1 $6.91 4/15/2020621,300 shares $4.86 million +29.6%0.9%0.6 $7.83 3/31/2020479,500 shares $3.94 million +30.5%0.7%0.5 $8.22 3/13/2020367,400 shares $2.31 million -5.8%0.5%0.4 $6.28 2/28/2020389,800 shares $2.05 million -5.2%0.6%0.3 $5.27 APTO Short Interest - Frequently Asked Questions What is Aptose Biosciences' current short interest? Short interest is the volume of Aptose Biosciences shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 993,200 shares of APTO short. 1.76% of Aptose Biosciences' shares are currently sold short. Learn More on Aptose Biosciences' current short interest. Which institutional investors are shorting Aptose Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptose Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptose Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.76% of Aptose Biosciences' floating shares are currently sold short. Is Aptose Biosciences' short interest increasing or decreasing? Aptose Biosciences saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 993,200 shares, a decrease of 24.2% from the previous total of 1,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptose Biosciences' float size? Aptose Biosciences currently has issued a total of 64,300,000 shares. Some of Aptose Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptose Biosciences currently has a public float of 56,470,000 shares. How does Aptose Biosciences' short interest compare to its competitors? 1.76% of Aptose Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Aptose Biosciences: Estrella Immunopharma, Inc. (0.10%), MiNK Therapeutics, Inc. (1.50%), Precision BioSciences, Inc. (20.79%), OKYO Pharma Limited (1.36%), Elevation Oncology, Inc. (16.86%), Passage Bio, Inc. (3.47%), Surrozen, Inc. (6.18%), Coeptis Therapeutics Holdings, Inc. (0.83%), Curis, Inc. (2.12%), Cyclo Therapeutics, Inc. (1.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Aptose Biosciences stock? Short selling APTO is an investing strategy that aims to generate trading profit from Aptose Biosciences as its price is falling. APTO shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptose Biosciences? A short squeeze for Aptose Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APTO, which in turn drives the price of the stock up even further. How often is Aptose Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APTO, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Estrella Immunopharma Short Interest Data MiNK Therapeutics Short Interest Data Precision BioSciences Short Interest Data OKYO Pharma Short Interest Data Elevation Oncology Short Interest Data Passage Bio Short Interest Data Surrozen Short Interest Data Coeptis Therapeutics Short Interest Data Curis Short Interest Data Cyclo Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APTO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptose Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APTO Stock Alerts